Home/AtomVie Global Radiopharma/Patrick Lim

PL

Patrick Lim

Chief Financial Officer

AtomVie Global Radiopharma

Therapeutic Areas

Oncology Diagnostics

AtomVie Global Radiopharma Pipeline

Drug	Indication	Phase
177Lu‑BetaBart (RV‑01)	Various solid tumors	Phase 1/2a
225Ac‑SSO110	Extensive‑stage small cell lung cancer and Merkel cell carcinoma	Phase 1/2

Leadership Team at AtomVie Global Radiopharma

Chief Executive Officer

Chief Operating Officer

View full AtomVie Global Radiopharma profile